Abstract

Toxoplasma gondii is a widespread protozoan parasite that causes potentially life-threatening opportunistic disease. New inhibitors of parasite replication are urgently needed, as the current antifolate treatment is also toxic to patients. Microtubules are essential cytoskeletal components that have been selectively targeted in microbial pathogens; further study of tubulin in Toxoplasma may reveal novel therapeutic opportunities. It has been noted that α-tubulin acetylation at lysine 40 (K40) is enriched during daughter parasite formation, but the impact of this modification on Toxoplasma division and the enzyme mediating its delivery have not been identified. We performed mutational analyses to provide evidence that K40 acetylation stabilizes Toxoplasma microtubules and is required for parasite replication. We also show that an unusual Toxoplasma homologue of α-tubulin acetyltransferase (TgATAT) is expressed in a cell cycle-regulated manner and that its expression peaks during division. Disruption of TgATAT with CRISPR/Cas9 ablates K40 acetylation and induces replication defects; parasites appear to initiate mitosis yet exhibit incomplete or improper nuclear division. Together, these findings establish the importance of tubulin acetylation, exposing a new vulnerability in Toxoplasma that could be pharmacologically targeted. IMPORTANCE Toxoplasma gondii is an opportunistic parasite that infects at least one-third of the world population. New treatments for the disease (toxoplasmosis) are needed since current drugs are toxic to patients. Microtubules are essential cellular structures built from tubulin that show promise as antimicrobial drug targets. Microtubules can be regulated by chemical modification, such as acetylation on lysine 40 (K40). To determine the role of K40 acetylation in Toxoplasma and whether it is a liability to the parasite, we performed mutational analyses of the α-tubulin gene. Our results indicate that parasites cannot survive without K40 acetylation unless microtubules are stabilized with a secondary mutation. Additionally, we identified the parasite enzyme that acetylates α-tubulin (TgATAT). Genetic disruption of TgATAT caused severe defects in parasite replication, further highlighting the importance of α-tubulin K40 acetylation in Toxoplasma and its promise as a potential new drug target.

Highlights

  • Toxoplasma gondii is a widespread protozoan parasite that causes potentially life-threatening opportunistic disease

  • Our results indicate that parasites cannot survive without K40 acetylation unless microtubules are stabilized with a secondary mutation

  • The spindle microtubules originate from a microtubule-organizing center (MTOC) termed the centrosome and ensure proper chromosome segregation and karyokinesis as the parasite completes each round of closed mitosis [13, 14]

Read more

Summary

Introduction

Toxoplasma gondii is a widespread protozoan parasite that causes potentially life-threatening opportunistic disease. Disruption of TgATAT with CRISPR/Cas ablates K40 acetylation and induces replication defects; parasites appear to initiate mitosis yet exhibit incomplete or improper nuclear division Together, these findings establish the importance of tubulin acetylation, exposing a new vulnerability in Toxoplasma that could be pharmacologically targeted. Genetic disruption of TgATAT caused severe defects in parasite replication, further highlighting the importance of ␣-tubulin K40 acetylation in Toxoplasma and its promise as a potential new drug target. While the immune system is capable of controlling the acute infection caused by the rapidly proliferating tachyzoite stage of the parasite, Toxoplasma is able to differentiate into a latent bradyzoite stage, establishing a chronic infection that remains for the life of the host Reactivation of these bradyzoite cysts in immunocompromised individuals can lead to debilitating or lifethreatening disease; for example, toxoplasmosis accounts for 10 to 30% of the deaths of HIV/AIDS patients [3, 4] and is a risk factor for patients receiving organ transplants or undergoing immunosuppressive chemotherapies [5,6,7,8]. The mechanisms by which Toxoplasma microtubules are regulated is an active area of inquiry

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.